Tafamidis Impurities are the unwanted substances present in Tafamidis, a medication used to treat a rare genetic disease called transthyretin amyloidosis. These impurities can affect the efficacy and safety of the drug and may cause adverse effects. Therefore, it is important to identify, monitor and control these impurities to ensure the quality, safety, and potency of the medication.
![4-[(3,5-dichlorobenzoyl)amino]-3-hydroxybenzoic acid](https://clearsynth.com/structure/4---3-5-dichlorobenzoyl-amino--3-hydroxybenzoic-acid.png "Tafamidis Impurities")
![methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate](https://clearsynth.com/structure/methyl-2--3-5-dichlorophenyl-benzo-d-oxazole-6-carboxylate.png "Tafamidis Impurities")
